Tolerance induction by a regulartory T cell-based cell therapy in living donor liver transplantation Tolerance induction by a regulartory T cell-based cell therapy in living donor liver transplantation ...
Tolerance induction by a regulartory T cell-based cell therapy in living donor liver transplantation - Operational tolerance by a Treg therapy in LDLT Tolerance induction by a regulartory T cell-based cell therapy in living donor liver transplantation ...
The patient is given cyclophosphamide (40mg/kg,iv) on postoperative days (POD) 5, and ex-vivo generated regulatory T cells on POD 13. Postoperative immunosuppression is with comventioal method. Tke immunosuppressant is reduced to 3/4 daily dose of the twice daily dose at 6 months, which is reduced to 3 times/week, 2 times/ week and 1 time/week every 3 months after confirming normal graft function and liver biopsy. the immunosuppressant is completely discontinued by 18 months after transplantation. The patient is given cyclophosphamide(40mg/kg,iv) on postoperative days (POD) 5, and ex-vivo generat ...